Resveratrol, a phytochemical, acts several cellular signaling pathways and has anti-inflammatory potentials. The purpose of this study is to research the therapeutic effect of resveratrol in collagen-induced arthritis (CIA) model in rats and whether resveratrol affects the activities of signaling pathways those are potent pathogenic actors of rheumatoid arthritis. Arthritis was induced by intradermal injection of chicken type II collagen combined with incomplete Freund's adjuvant in Wistar albino rats. One day after the onset of arthritis (day 14), resveratrol (20 mg/kg/day) was given via oral gavage, until day 29. The paws of the rats were obtained for further analysis. Tissue Wnt5a, mitogen-activated protein kinase (MAPK), Src tyrosine kinase and signal transducer, and activator of transcription-3 (STAT3) mRNA expressions were determined by real-time polymerase chain reaction. Resveratrol ameliorated the clinical and histopathological (perisynovial inflammation and cartilagebone destruction) findings of inflammatory arthritis. The tissue mRNA expressions of Wnt5a, MAPK3, Src kinase, and STAT3 were increased in the sham group compared to the control group. Resveratrol supplement decreased their expressions. The present study shows that Src kinase, STAT3, and Wnt signaling pathway are active in the CIA model. Resveratrol inhibits these signaling pathways and ameliorates inflammatory arthritis. © 2018 BioFactors, 45(1): [69][70][71][72][73][74] 2019 Keywords: rheumatoid arthritis; collagen induced arthritis; resveratrol Abbreviations: CIA, collagen-induced arthritis; COX-2, cyclooxygenase-2; DMARDs, disease-modifying anti-rheumatic drugs; FLS, fibroblast-like synoviocyte; GSH, glutathione; GSK-3β, glycogen synthase kinase-3 beta; MALAT1, metastasis-associated lung adenocarcinoma transcript 1; MDA, malondialdehyde; MMP, matrix metalloproteinase; PGE2, prostaglandin; PIAS, protein inhibitor of activated STAT; PTP, protein tyrosine phosphatases; RA, rheumatoid arthritis; RANKL, receptor activator of nuclear factor kappa-B ligand; SHP-2, SH2 domain-containing tyrosine phosphatase; SMAD, small mothers against decapentaplegic; STAT, signal transducer and activator of transcription; TNF-α, tumor necrosis factor; TRAIL, tumor necrosis factor-related apoptosisinducing ligand; VSMC, vascular smooth muscle cells
Introduction
Rheumatoid arthritis (RA) is a chronic inflammatory disease, and it leads to disability due to cartilage and bone destructions [1] . Several synthetic and biologic disease-modifying antirheumatic drugs (DMARDs) are widely used to treat RA patients to achieve remission or at least low/minimal disease activity. However, a portion of patients still have the inadequate response to DMARDs, and these agents lead to a high incidence of adverse reactions [1] . Therefore, complementary and alternative medicine interventions, especially the supplements of nutrients, have become popular in the treatment of RA in worldwide. The antiarthritic actions of resveratrol are shown by experimental and clinical studies [2, 3] .
Resveratrol is a polyphenolic phytoalexin, and this phytochemical is extensively studied in different cancers and inflammatory disorders [4, 5] . It regulates oxidative stress, and this action is accepted as the main cause of anti-inflammatory activity. However, resveratrol acts cell signaling pathways [Wnt, small mothers against decapentaplegic (SMAD), tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL), and signal transducer and activator of transcription (STAT)] [4, [6] [7] [8] [9] , and it is capable of inhibiting prominent cytokines, such as TNF-α, interleukin (IL)-17, IL-6, and IL-1β [5] . Almost all affected issues by resveratrol, mentioned above, have also roles in the pathogenesis of RA.
Wnt/β-catenin signaling pathway act several important functions, such as embryonic development, limb development, joint formation, and cell differentiation [10, 11] . Recent findings have suggested that this signaling pathway plays prominent roles on the fibroblast-like synoviocyte (FLS) activation, and joint/cartilage destructions in RA [11] . Wnt5a, a member of the Wnt protein family, is expressed by FLS in RA but not in normal tissue [12] . β-catenin which is a regulatory factor in the Wnt/β-catenin signaling pathway activation and the expression of β-catenin is upregulated in cultured FLS from RA patients when compared with that in FLS, harvested from patients with osteoarthritis [13] .
The purpose of our study was to research the therapeutic effect of resveratrol in collagen-induced arthritis (CIA) model in rats, and whether resveratrol affects the activities of Src kinase, STAT3, and Wnt/β-catenin signaling pathways in CIA.
Material and methods

Animals
The experiment was conducted with 30 Wistar-Albino female rats. Rats were 10 weeks old with weights varying between 200 and 250 g. Rats were kept in separate cages at a humidity rate of 55 AE 5% and a temperature rate of 22 AE 2 C for 12-h photophase and 12-h scotophase. Standard rat food was used in their nutrition while they were given ad libitum access to water. The local ethics board accepted the study protocol.
Experimental design
The study was conducted by dividing into three groups: control, arthritis (placebo), and resveratrol treatment groups. Each group consisted of 10 subjects. Type 2 collagen (Sigma Aldrich company, St. Louis, MO) was diluted with 0.1 M acetic acid to have 1 mg in 1 ml. The equal volume of Freund's adjuvant (Difco Laboratories, Detroit, MI) was added. The solution was injected intradermally to the tail dorsal (100 μg) and back paws (50 μg to each paw and total 200 μg to each rat) as described before. After 7 days, 100 μg booster injections were made to each rat as described. Development of arthritis after the collagen injection was evaluated separately for each rat by clinical scoring. Arthritis scorings in three groups were done according to the previously described method (Table 1 ) [14] . One day after the onset of arthritis (day 14), resveratrol (20 mg/kg/day) was given via oral gavage.
Sample acquisition
Rats were sacrificed after 15 days the beginning of the arthritis development (14th day) at the 29th day. Back paws were amputated under the knee joint for histopathologic examinations and blood samples were taken for biochemical analyses. The blood samples were kept until analysis at −20 C. Joint samples were divided into two sections. Some of them for the real-time PCR analyses were kept at −80 C without making any operation.
The remaining part was taken into 10% formaldehyde for histopathologic examinations and decalcified as described before [15, 16] . The Hematoxylin-Eosin (H & E) stained lames were evaluated blindly by a pathologist as described before for arthritis scoring (Tables 2 and 3 ) [15, 16] .
Real-time PCR analysis
Total RNA was isolated using TRIzol reagent (Invitrogen, Carlsbad, CA) from paws. cDNAs were generated by reverse transcription of total RNA samples with appropriate commercial cDNA Synthesis kit (Invitrogen, Carlsbad, CA). PCR reactions were prepared in triplicate (heated to 50 C for 2 min followed by 40 cycles of denaturation at 95 C for 10 min, 95 C for 15 sec and 60 C for 1 min). Standard curves (cycle threshold values versus template concentration) were prepared for each
TABLE 1
Arthritis scoring according to clinical findings [14] Clinical findings Score
No arthritis 0
Mild erythema and edema in the foot or ankle 1
Mild erythema and edema in the paw 2
Moderate erythema and edema in the paw 3
Marked edema and anchylosis, and restricted movement in the paw target gene and for the endogenous reference (HPRT) in each sample. A real-time PCR analysis was performed with the ABI Prism 7500 Fast real-time PCR Instrument (Applied Biosystems, Foster City, CA) using Tag Man Master Mix (Applied Biosystems). All results were standardized to the levels of GAPDH. The samples were quantified for Src, Fyn, MAPK, and STAT3 genes using the comparative Ct (ΔΔCt) method, as described in the Assays-on-Demand User's Manual (Applied Biosystems).
Statistical analysis
Data were analyzed using the International Business Machines -Statistical Product and Service Solutions (IBM-SPSS, version 21.0) software (IBM Corp., Armonk, NY). Data were expressed as the mean AE standard deviation. Data were analyzed with Kruskal-Wallis variance analysis. Mann-Whitney U test was used for dual comparisons. Categorical data were analyzed by the Chi-square test. The differences in the arthritis scoring between the 14th and 29th days were evaluated with the Wilcoxon rank-sum test. All P values less than 0.05 were accepted statistically significant.
Results
Arthritis was clinically developed at 12-13 days after the injection of collagen (Fig. 1) . The mean arthritis scores were 2.4 AE 0.5 and 2.6 AE 0.5 in the sham and resveratrol groups, respectively. And, these scores were significantly higher than in the control group (P < 0.001 for both). The 29th-day scores were decreased in the resveratrol group compared to the own 13th-day score (2.6 AE 0.5 vs. 0.5 AE 0.7, Wilcoxon Rank P < 0.05). Moreover, the mean 29th-day score of resveratrol group were decreased compared to the mean 29th-day score of sham group (0.5 AE 0.7 vs. 2.5 AE 0.8, P < 0.001). However, the mean 29th-day score and 13th-day score were similar in the sham group (2.4 AE 0.5 vs. 2.5 AE 0.8, Wilcoxon Rank P > 0.05). The extensive perisynovial inflammation and marked cartilage-bone destruction in the sham (arthritis) group rats were demonstrated by histopathological analysis compared to the control group (P < 0.001 for both). Resveratrol treatment decreased the perisynovial inflammation and cartilage-bone destruction in the paws (Fig. 2) compared to the sham group (P < 0.01 for both).
The tissue mRNA expressions of MAPK, Src kinase, STAT3, and Wnt5a were increased in the sham group compared to the control group (Fig. 3) . However, resveratrol treatment decreased their expressions.
Discussion
Previous studies have shown that resveratrol has several antiinflammatory effects [2] [3] [4] [5] 17] . In the CIA model, we found that resveratrol inhibited Src tyrosine kinase, STAT3, and Wnt signaling pathways, resveratrol-ameliorated inflammatory arthritis.
Resveratrol, a natural product found in most grape cultivars, is well-known the anti-inflammatory, anti-oxidant, antiaging, anticarcinogenic, cardio-protective, and neuro-protective
TABLE 2
Histopathologic assessment of inflammation severity [15, 16] Perisynovial tissue (PT) inflammation severity Score
Normal PT 0
PT inflammation, no aggregates 1 PT inflammation, occasional, small, focal aggregates 2
Moderate PT inflammation, many small aggregates 3
Diffuse PT inflammation and large aggregates 4
TABLE 3
Histopathologic assessment of arthritis severity [15, 16] Arthritis severity Score
Normal cartilage and bone tissue 0
Synovial hyperplasia or hypertrophy 1
Pannus or superficial cartilage erosion 2
Subchondral erosion, mild bone erosion 3
Marked bone erosion 4
FIG 1
The mean daily arthritis score in all the study groups. *The mean arthritis scores were higher in the sham and resveratrol groups compared to the control group (P < 0.001 for all).
x The 29th day arthritis scores were decreased in the resveratrol group compared to the own 13th day score (Wilcoxon Rank P < 0.05).
‡29th day arthritis score of resveratrol group was decreased compared to the 29th day score of sham group (P < 0.001).
properties of resveratrol. There are both human and animal studies related to anti-arthritic effects of resveratrol. Although oral bioavailability of resveratrol is weak, promising results will be obtained in real life by developing different methods of administration [18] . Especially in studies related to rheumatic diseases, it was known that the immunomodulatory properties of resveratrol are caused by reducing some pro-inflammatory factors and affecting the immune response. It has been shown that resveratrol inhibits the activity of FLS, collected from patients with RA (RA-FLS) in in vitro settings [19, 20] . RA-FLSs are the prominent actor of RA pathogenesis, and they overproduce matrix metalloproteinase (MMP) and receptor activator of nuclear factor kappa-B ligand (RANKL) those are responsible for causing chondrocyte degeneration and pathological bone erosions [1] . Resveratrol has been shown to reduce the expression of MMP and RANKL from RA-FLSs [19, 20] . Moreover, antiarthritic potentials have been shown in in vivo settings (various experimental arthritis models) [21] [22] [23] [24] [25] . Riveiro-Naveira et al. [21] have reported that resveratrol reduces the severity of arthritis and joint swelling in the CIA model. Elmali et al. [22] have shown that intra-articular resveratrol injections ameliorate the synovial inflammatory cells infiltration and cartilage destruction by histopathological evaluations in rabbit arthritis model. Similarly, dietary resveratrol supplements reduced the edema and erythema of paws and ameliorated periarticular inflammatory cell invasions and cartilage-bone destruction in the CIA model, in our study. Xuzhu et al. [23] have demonstrated that resveratrol modulates inflammatory arthritis in rodents by selectively suppressing the activity of Th17 cell and the productions of proinflammatory cytokines (TNF-α, IL-1, IL-6, and IL-17) necessary for the pathogenesis of arthritis. Chen et al. [24] have reported that the anti-arthritic effects of resveratrol are associated with the reduction of cyclooxygenase-2 (COX-2) and prostaglandin E2 (PGE2). On the other hand, Wahba et al. [25] have shown that resveratrol suppresses malondialdehyde (MDA) level and increases glutathione (GSH) level and that antiarthritic potential of resveratrol is related with ameliorating oxidative stress. In our study, resveratrol inhibited the over-expression of MAPK3, Src kinase, and STAT3 mRNA by joints. These results suggest that the main act of resveratrol on arthritis is caused by its effects on inflammatory ways. Since these intracellular signaling ways are induced by pro-inflammatory cytokines, and they are responsible for the aberrant survival of immune cells [26] .
Resveratrol has been shown to inhibit the Src kinase activity in various malignant cell cultures [27] . Moreover, resveratrol is reported to inhibit Src kinase activity in vascular smooth muscle cells (VSMC) using in vitro (angiotensin II-induced of VSMC hypertrophy model) and in vivo (hyperproliferation of VSMC from spontaneously hypertensive rats) settings [28, 29] . Src kinases are important in the activation of several inflammatory cells including macrophage, dendritic cells, neutrophils, and natural killer cells, and thus, they affect both innate and adaptive immune responses [30] . It is also known that the Src tyrosine kinase activates STAT3 [31] . STAT3 is a member of the STAT family. STATs are the prominent actors of RA pathogenesis and STAT3 expression and activity are known to contribute to the onset, progression, and severity of RA [32, 33] . Resveratrol has been shown to repress the aberrant STAT3 signaling in malignant cells [27] . Limagne et al. [34] have reported that resveratrol inhibits the IL-6 and IL-1β induced STAT3 activation in the cell culture of macrophages. It is known that resveratrol increases negative regulators of STAT signaling [SH2 domain-containing tyrosine phosphatase (SHP-2), protein inhibitor of activated STAT (PIAS), and protein tyrosine phosphatases (PTP)], and thus, it inhibits the activation of STAT [5] . In our study, resveratrol decreased the mRNA expression of STAT3. Therefore, it can be concluded that the anti-arthritic effect of resveratrol is caused by the inhibitory action on Src kinase and by the depletion of STAT3 expression, in the CIA model.
Recent findings have suggested that the Wnt signaling pathway plays a key role in the FLS activation, bone resorption, and joint destruction in RA [11] . Wnt5a, a member of the Wnt protein family, is expressed by FLS in RA but not in normal tissue [12] . Expressions of β-catenin which is the key regulatory factor in the canonical Wnt signaling pathway activation are shown to be up-regulated in cultured FLS from RA patients when compared with that in FLS harvested from patients with osteoarthritis [13] . In our study, the increased expression of Wnt5a mRNA in the CIA model suggests the pathogenic roles of Wnt signaling pathway on inflammatory arthritis.
Resveratrol supplements decreased Wnt5a mRNA expression in the CIA model, in our study. Previous articles have shown that resveratrol down-regulates Wnt signaling pathway in various in vitro settings (malign cell and cardiomyocyte cell cultures) [5] [6] [7] . Wnt ligands are secreted glycoproteins. They bind to receptors to build a larger cell surface complex with low-density lipoprotein receptor-related protein. When a Wnt glycoprotein does not bind to the surface receptor, the destruction complex leads to ubiquitination and degradation of β-catenin, by proteasomal machinery. When the Wnt pathway is active, β-catenin moves into the nucleus to trigger the expression of target genes. Resveratrol reduces the overexpression of β-catenin and decreases the phosphorylation of glycogen synthase kinase-3 beta (GSK-3β), in xenograft breast tumors and HCT116 cell line [35, 36] . Moreover, resveratrol exerted inhibitory effects on the Wnt pathway through the down-regulation of metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) which is a long non-coding RNA [37] .
The present study has several limitations. The first, it documents the early therapeutic of resveratrol applications on arthritis; however, its prophylactic effects could also be researched. The second, radiographic progressions need to be evaluated. The third, the effect of resveratrol on control rats could be shown. Moreover, the impact of resveratrol on mRNA levels of Src kinase, STAT3, and Wnt5a were evaluated but not on protein levels, in our study.
In conclusion, many drugs have been developed as a result of in vivo and in vitro studies for effective treatment of RA. In fact, despite new treatment agents in RA, the search for the effective treatment is still ongoing. The present study shows that resveratrol ameliorates arthritis in the CIA model. Moreover, in this experimental model, resveratrol inhibits Src kinase, STAT3, and Wnt signaling pathway those are the current popular pathogenic actor of RA pathogenesis. This study provides important information on the mechanism of action as well as the anti-arthritic effect of resveratrol.
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